nNOS-expressing neurons in the vmPFC transform pPVT-derived chronic pain signals into anxiety behaviors.
Hai-Ying LiangZhi-Jin ChenHui XiaoYu-Hui LinYing-Yi HuLei ChangHai-Yin WuPeng WangWei LuDong-Ya ZhuChun-Xia LuoPublished in: Nature communications (2020)
Anxiety is common in patients suffering from chronic pain. Here, we report anxiety-like behaviors in mouse models of chronic pain and reveal that nNOS-expressing neurons in ventromedial prefrontal cortex (vmPFC) are essential for pain-induced anxiety but not algesia, using optogenetic and chemogenetic strategies. Additionally, we determined that excitatory projections from the posterior subregion of paraventricular thalamic nucleus (pPVT) provide a neuronal input that drives the activation of vmPFC nNOS-expressing neurons in our chronic pain models. Our results suggest that the pain signal becomes an anxiety signal after activation of vmPFC nNOS-expressing neurons, which causes subsequent release of nitric oxide (NO). Finally, we show that the downstream molecular mechanisms of NO likely involve enhanced glutamate transmission in vmPFC CaMKIIα-expressing neurons through S-nitrosylation-induced AMPAR trafficking. Overall, our data suggest that pPVT excitatory neurons drive chronic pain-induced anxiety through activation of vmPFC nNOS-expressing neurons, resulting in NO-mediated AMPAR trafficking in vmPFC pyramidal neurons.
Keyphrases
- chronic pain
- spinal cord
- pain management
- nitric oxide
- nitric oxide synthase
- sleep quality
- prefrontal cortex
- high glucose
- diabetic rats
- end stage renal disease
- drug induced
- dna methylation
- neuropathic pain
- physical activity
- gene expression
- spinal cord injury
- newly diagnosed
- prognostic factors
- oxidative stress
- ejection fraction
- depressive symptoms
- electronic health record
- peritoneal dialysis
- machine learning
- hydrogen peroxide
- brain injury
- blood brain barrier